abatacept January 9, 2018checkorphan abatacept Trade Name Orencia Orphan Indication Ataxia Telangiectasia USA Market Approval USA USA Designation Date 2018-01-09 00:00:00 Sponsor Bristol-Myers Squibb Co. P.O Box 4000 Princeton, New Jersey, 08543
